US Stock MarketDetailed Quotes

AUTL Autolus Therapeutics

Watchlist
  • 1.730
  • -0.020-1.14%
Close Feb 28 16:00 ET
  • 1.760
  • +0.030+1.73%
Post 20:01 ET
460.39MMarket Cap-1.42P/E (TTM)

About Autolus Therapeutics Company

Autolus Therapeutics Plc is a biopharmaceutical company, which engages in the development and commercialization of gene therapies. It uses proprietary and modular T cell programming technologies that are designed to recognize cancer cells, break down their defense mechanisms, and attack and kill these cells. The company was founded by Martin Pule in September 2014 and is headquartered in London, the United Kingdom.

Company Profile

SymbolAUTL
Company NameAutolus Therapeutics
Listing DateJun 22, 2018
Issue Price17.00
Founded2018
CEODr. Christian Itin, PhD.
MarketNASDAQ
Employees471
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
AddressThe Mediaworks,191 Wood Lane,White City
CityLondon
ProvinceGreater London
CountryUnited Kingdom of Great Britain and Northern Ireland (the)
Zip CodeW12 7FP
Phone44-20-3829-6230
Websitehttp://www.autolus.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Christian Itin, PhD.
  • Chief Executive Officer and Director
  • 1.92M
  • Martin Pule
  • Senior Vice President and Chief Scientific Officer
  • --
  • Dr. Edgar Braendle
  • Senior Vice President and Chief Development Officer
  • --
  • Brent Rice
  • Senior Vice President and Chief Commercial Officer
  • --
  • Robert F. Dolski
  • Senior Vice President, Chief Financial Officer
  • --
  • Christopher Vann
  • Senior Vice President and Chief Operating Officer
  • --
  • Alexander Swan
  • Senior Vice President, Chief Human Resources Officer
  • --
  • Dr. Christopher Willia PhD
  • Senior Vice President and Chief Business Development Officer
  • --
  • David Brochu
  • Senior Vice President and Chief Technical Officer
  • --
  • Michael W. Bonney
  • Chairman of the Board
  • --
  • Robert W. Azelby
  • Director
  • --
  • Dr. Ravi Madduri Rao
  • Director
  • --
  • Dr. Elisabeth Leiderman, M.D.
  • Director
  • 12.73K
  • William D. Young
  • Independent Director
  • 175.82K
  • John E. Berriman
  • Independent Director
  • 163.15K
  • Dr. Martin Murphy, PhD
  • Independent Director
  • 158.28K
  • Linda C. Bain
  • Independent Director
  • 169.52K
  • Cynthia M. Butitta
  • Independent Director
  • 164.65K
  • Dr. Joseph Anderson, PhD.
  • Independent Director
  • 195.65K
  • Dr. Robert Iannone, M.D.
  • Independent Director
  • 134.86K
Trending Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
TeraWulf
WULF
+16.07%
Bitdeer Technologies
BTDR
+13.04%
Riot Platforms
RIOT
+7.16%
Bitfarms
BITF
+6.42%
Strategy
MSTR
+6.41%

Unlock the Full List